# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-16-000065
Filing Date
2016-07-21
Accepted
2016-07-21 17:30:12
Documents
120
Period of Report
2016-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2016630x10q.htm | 10-Q | 1799808
2 | EXHIBIT 10.1 | biib-2016630xex101.htm | EX-10.1 | 41331
3 | EXHIBIT 31.1 | biib-2016630xex311.htm | EX-31.1 | 14191
4 | EXHIBIT 31.2 | biib-2016630xex312.htm | EX-31.2 | 14875
5 | EXHIBIT 32.1 | biib-2016630xex321.htm | EX-32.1 | 10744
12 |  | biib-2016630_alprolix.jpg | GRAPHIC | 36246
13 |  | biib-2016630_amortization.jpg | GRAPHIC | 25038
14 |  | biib-2016630_anticd20revenue.jpg | GRAPHIC | 41313
15 |  | biib-2016630_benepali.jpg | GRAPHIC | 24522
16 |  | biib-2016630_cogs.jpg | GRAPHIC | 35994
17 |  | biib-2016630_collabloss.jpg | GRAPHIC | 21954
18 |  | biib-2016630_eloctate.jpg | GRAPHIC | 36212
19 |  | biib-2016630_equityinloss.jpg | GRAPHIC | 21846
20 |  | biib-2016630_finhighlights.jpg | GRAPHIC | 40128
21 |  | biib-2016630_gainlossfairval.jpg | GRAPHIC | 23652
22 |  | biib-2016630_incometaxes.jpg | GRAPHIC | 34084
23 |  | biib-2016630_interferon.jpg | GRAPHIC | 38084
24 |  | biib-2016630_oie.jpg | GRAPHIC | 24693
25 |  | biib-2016630_otherrevenues.jpg | GRAPHIC | 33762
26 |  | biib-2016630_randdpiechart15.jpg | GRAPHIC | 37109
27 |  | biib-2016630_randdpiechart16.jpg | GRAPHIC | 36657
28 |  | biib-2016630_researchanddev.jpg | GRAPHIC | 84215
29 |  | biib-2016630_reserves.jpg | GRAPHIC | 51050
30 |  | biib-2016630_restructuring.jpg | GRAPHIC | 19913
31 |  | biib-2016630_sellgenandadmin.jpg | GRAPHIC | 35788
32 |  | biib-2016630_tecfidera.jpg | GRAPHIC | 42060
33 |  | biib-2016630_tysabri.jpg | GRAPHIC | 38746
34 |  | biogenlogostandard.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-16-000065.txt |  | 12033816

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | biib-20160630.xml | EX-101.INS | 2461569
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20160630.xsd | EX-101.SCH | 68795
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20160630_cal.xml | EX-101.CAL | 98257
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20160630_def.xml | EX-101.DEF | 305478
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20160630_lab.xml | EX-101.LAB | 850738
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20160630_pre.xml | EX-101.PRE | 486406

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 161778025
SIC: 2836 Biological Products, (No Diagnostic Substances)